Recombinant Human CMA1 Protein，His

CMA1 (Cationic antimicrobial protein 1) is a significant protein involved in the innate immune response, particularly in the context of antimicrobial defense and inflammation. The study of recombinant CMA1 proteins has gained prominence due to their potential applications in biomedicine, including as therapeutic agents against various infections and as tools for understanding immune mechanisms. Traditionally, CMA1's role in host defense against pathogens such as bacteria and fungi has been well documented, but recent research has expanded its relevance to cancer immunotherapy and wound healing. The production of recombinant CMA1 allows for the detailed study of its structure-function relationship, facilitating the examination of its antimicrobial properties and mechanisms of action at a molecular level. By leveraging recombinant DNA technology, researchers can produce large quantities of CMA1 in host systems, such as bacteria or yeast, ensuring a steady supply for experimental purposes. Furthermore, insights gained from these studies can lead to the development of novel antimicrobial compounds, enhance vaccine efficacy, and provide a better understanding of autoimmune diseases. As research continues to unravel the complexities of CMA1's interactions within the immune system, there is a growing interest in exploring its therapeutic potential, making the study of CMA1 recombinant proteins a crucial area within molecular biology and immunology.